Current Treatment Strategies

Polypharmacy in the Elderly, Overview of Drug Interactions and Internal Medicine  Jeopardy  

5 hours | Wednesday, 12/7/2022
Check-in and Breakfast: 7:30AM
Educational Session: 8:00AM – 1:30PM

At the conclusion of this program, the participant will be able to:
Polypharmacy in the Elderly: Pitfalls, Pearls, and Plan:  1. Recognize factors leading to polypharmacy in the elderly. 2. Define inappropriate medications for elderly patients. 3. Describe tools to screen patients for polypharmacy. 4. Delineate best practices in polypharmacy through patient cases.  Overview of Drug Interactions:  5.  Identify common drug interaction mechanisms including cytochrome P450 enzymes. 6. Identify ten relevant clinical drug interactions for common medications.  7.  Delineate assessment and management strategies for each drug interaction.  Internal Medicine  Jeopardy:   8. Identify evidenced-based guideline directed pharmacotherapy for select disease states.  9. Identify key therapeutic laboratory indices for selecting pharmacotherapy.

Expert Speaker 

GI Topics : Peptic Ulcer Disease and Helicobacter Highlights, Inflammatory Bowel Disease:, Probiotics, C difficile Update., Bootcamp for Elevated Liver Function Tests and  Drug Induced Liver Injury 
5 hours | Thursday, 12/8/2022
Check-in and Breakfast: 7:30AM
Educational Session: 8:00AM – 1:30PM

At the conclusion of this program, the participant will be able to:

Peptic Ulcer Disease and Helicobacter Highlights

1. Identify the importance of risk factors in the development of UGI bleeding. 2. Select the appropriate candidates for long term PPI therapy. 3. Review the non invasive ways of making a H pylori diagnosis. 4. Manage antibiotic therapy for Helicobacter 2022

Inflammatory Bowel Disease: What You Need to Know

5. Distinguish Inflammatory Bowel Disease (IBD) from Irritable Bowel Syndrome (IBS). 6. Describe the workup of IBD. 7. Describe the various treatments for IBD. 8. Discuss the controversies surrounding IBD.

Probiotics: Fulfilling the Promise? And C difficile Update.

9. Describe the proven GI uses of probiotics. 10. Recognize the difficulty in comparing strains, studies and results. 11. Define how to best diagnose and treat Cl difficile. 12. Recognize how fecal transplants may be the ultimate probiotic. 13. Identify future uses of probiotics.

Bootcamp for Elevated Liver Function Tests

14. Define Non Alcoholic Fatty Liver Disease (NAFLD) and Non Alcoholic Steato Hepatitis (NASH). 15. Recognize frequently encountered gallbladder and common duct dilemmas. 16. Identify the changing paradigm in Hemochromatosis evaluation. 17. Describe what a primary care provider should know about Hepatitis C.

Drug Induced Liver Injury 

18. Describe the various subtypes of DILI 19. Describe the differential diagnosis of DILI. 20. Examine the risk factors for DILI deterioration. 21. Examine when a liver biopsy may help make the diagnosis.

Expert Speaker

Opioids and Alternatives- Strategies to Optimize Success

5 hours | Friday 12/9/2022
Check-in and Breakfast: 7:30AM
Educational Session: 8:00AM – 1:30PM

Opioids and Alternatives- Strategies to Optimize Success”

At the conclusion of this program, the participant will be able to:

1. Describe how the role for the use of opioids in acute, chronic, cancer/palliative care and end-of-life pain has changed in the past decade.  2. Describe the key features of the 2022 Proposed CMS Recommendations/Guidelines for prescribing opioids for outpatients.  3. Differentiate addiction, physical dependency, and tolerance.  4. State key principles managing patients with ongoing therapy that includes opioid analgesics, including stating “red flags” for opioid misuse, abuse and diversion, and how to anticipate and manage adverse drug events.  5. Identify the main characteristics of patients who would be identified as “high risk”, “moderate risk” and “low risk” for chronic opioid use.  6. State the definition of “hyperalgesia” and how to prevent/minimize this from negatively influencing the care of patients who are receiving opioids.  7. State three reasons why opioids may not be effective for some patients with chronic pain.  8. State key educational principles that should be applied to all  patients and caregivers regarding the safe use, proper storage and disposal of opioids.   9.Compare and contrast the pharmacological benefits and risks of the following non-opioid pharmacological options for managing pain:  a) cannabinoids; b) NSAIDS;  c) anti-convulsants; and, d) anti-depressants.

Expert Speaker